| abstract |
The present invention relates to compositions and methods of use thereof for the treatment of lymphoma. In one aspect, the present invention provides a method of treating lymphoma in an individual who has received or is receiving chemotherapy that includes an anthracycline and/or an alkylating agent, the method comprising administering a CD83 binding protein conjugated to a cytotoxic agent to the individual, thereby treating lymphoma in the individual. The invention also relates to the use of treating lymphoma with an activator of NF-κB and a CD83 binding protein conjugated to a cytotoxic agent. |